Overview of Larin Fe 1.5/30
Quick Facts
| Property | Description |
|---|---|
| Active ingredients | Norethindrone acetate and Ethinyl estradiol |
| Form | Oral tablet (monophasic) |
| Pharmacological class | Combined hormonal contraceptive (CHC) |
| Common use | Contraception (pregnancy prevention) |
| Origin | Synthetic hormones |
What is Larin Fe 1.5/30? Identity and Composition Overview
Larin Fe 1.5/30 is a prescription-only oral tablet medication belonging to the pharmacological class of Combined Hormonal Contraceptives (CHC). The primary purpose of this medication is to provide effective prevention of pregnancy in women who choose this method of contraception. It is a synthetic combination formulation administered orally in a structured 28-day regimen.
Pharmaceutical Class and Form Differentiation
Larin Fe 1.5/30 is categorized as a monophasic Combined Hormonal Contraceptive (CHC) in the oral tablet drug form. This monophasic characteristic signifies that the 21 active tablets maintain a fixed, unchanging concentration of the two hormones throughout the active phase of the cycle. This fixed-dose approach provides a predictable hormonal input, which may be preferred over the shifting levels found in multiphasic contraceptives. Oral contraceptives that combine ethinyl estradiol and norethindrone work mainly by preventing ovulation.
Composition: Synthetic Hormones and Ferrous Fumarate (Fe)
The active components in the yellow tablets are the synthetic progestin Norethindrone acetate and the synthetic estrogen Ethinyl estradiol. A distinguishing feature of Larin Fe 1.5/30 is the "Fe" component, which stands for Ferrous fumarate, an iron compound included in the seven inactive tablets taken during the final week. This component is included to facilitate continuous administration via a 28-day regimen and does not provide a therapeutic contraceptive effect. Other medications share this Norethindrone/Ethinyl Estradiol active combination, but the specific monophasic dosage and integrated iron component define the identity of the Larin Fe 1.5/30 formulation.
Regulatory References

